Evidence map›Paper›PMID 37489950›Full record

Observational studyJournal of comparative effectiveness research2023

Healthcare resources and costs associated with nonvalvular atrial fibrillation in Spain: apixaban versus acenocoumarol.

Josep Comín Colet, Antoni Sicras Mainar, Joel Salazar-Mendiguchía, María Isabel Del Campo Alonso, Ainara Echeto, David Vilanova Larena, Olga Delgado Sánchez

Open access · diamondAbstract readObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in Journal of comparative effectiveness research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
0.2field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it, 1 citations in OpenAlex.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Josep Comín ColetCardiology Department, Hospital Universitari de Bellvitge (IDIBELL) & CIBERCV, 08907, L'Hospitalet de Llobregat, Spain.ORCID 0000-0001-8780-720X
Antoni Sicras MainarHealth Economics & Outcomes Research, Atrys Health, 28002, Madrid, Spain.ORCID 0000-0002-8232-293X
Joel Salazar-MendiguchíaBristol Myers Squibb, 28050, Madrid, Spain.ORCID 0000-0003-2171-8508
María Isabel Del Campo AlonsoBristol Myers Squibb, 28050, Madrid, Spain.
Ainara EchetoBristol Myers Squibb, 28050, Madrid, Spain.
David Vilanova LarenaBristol Myers Squibb, 28050, Madrid, Spain.
Olga Delgado SánchezPharmacy Department, Son Espases University Hospital, IdISBa, 07120, Palma, Spain.ORCID 0000-0002-6482-301X
Bellvitge University Hospital · ESHealth Research Institute of the Balearic Islands · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Atrial FibrillationStrokeAcenocoumarolAnticoagulantsDelivery of Health CareHumansPyrazolesPyridonesRetrospective StudiesRivaroxabanSpainAcenocoumarolAnticoagulantsapixabanPyrazolesPyridonesRivaroxabanacenocoumarolapixabancardiovascular eventscost–effectivenesshealthcare resources

Identifiers

PMID37489950
PMCPMC10508311
OpenAlexW4385230379

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.